US Broker Ratings

Bioventus Inc. (BVS) Stock Analysis: Navigating Growth in the Medical Device Sector with a 30.86% Upside Potential

Bioventus Inc. (NASDAQ: BVS), a prominent player in the healthcare sector, specifically within the medical devices industry, presents a compelling investment case, particularly for those seeking..

Sonida Senior Living, Inc. (SNDA): Investor Outlook with a 31% Potential Upside

Sonida Senior Living, Inc. (SNDA), a significant player in the healthcare sector, specifically within the medical care facilities industry, has been catching the attention of investors..

Arvinas, Inc. (ARVN) Stock Analysis: Evaluating a Potential 87% Upside in Innovative Protein Degradation Therapies

Arvinas, Inc. (NASDAQ: ARVN), a pioneering biotechnology firm based in New Haven, Connecticut, is at the forefront of developing cutting-edge therapies that leverage the body’s natural..

Altimmune, Inc. (ALT) Stock Analysis: A Biotech Gem with 520% Potential Upside

Altimmune, Inc. (NASDAQ: ALT), a key player in the biotechnology sector, is drawing investor attention with its compelling growth potential. Despite a modest market cap of..

Praxis Precision Medicines, Inc (PRAX) Investor Outlook: A High-Stakes Bet with 124% Potential Upside

In the dynamic world of biotechnology, Praxis Precision Medicines, Inc. (NASDAQ: PRAX) stands out as a compelling, albeit risky, opportunity for investors seeking exposure to groundbreaking..

Auna SA (AUNA) Stock Analysis: Uncovering a 40% Potential Upside in the Healthcare Sector

Auna SA (AUNA), a Luxembourg-based healthcare service provider, has been making waves in the medical care facilities industry with its operations spanning across Mexico, Peru, and..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Unpacking a Potential 166% Upside

Gyre Therapeutics, Inc. (NASDAQ: GYRE) is a biotechnology company headquartered in San Diego, California, specializing in the development and commercialization of small-molecule drugs targeting organ fibrosis..

Maravai LifeSciences Holdings (MRVI) Stock Analysis: Navigating the Biotech Wave with Strategic Insight

In the competitive realm of biotechnology, Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI) stands as a pivotal player, offering essential products that drive the development of drug..

Valneva SE (VALN) Stock Analysis: Navigating 107.63% Potential Upside Amid Challenging Metrics

Valneva SE (VALN), a notable player in the biotechnology sector, operates out of France with a keen focus on developing vaccines for infectious diseases with significant..

Capricor Therapeutics, Inc. (CAPR) Stock Analysis: Unraveling a 202% Potential Upside in the Biotech Sector

Capricor Therapeutics, Inc. (NASDAQ: CAPR) has captured the attention of investors with its staggering potential upside of 202.01%, according to recent analyst ratings. As a clinical-stage..

Trevi Therapeutics, Inc. (TRVI) Stock Analysis: A Biotech with Nearly 99% Upside Potential

Trevi Therapeutics, Inc. (NASDAQ: TRVI) is capturing significant attention in the biotechnology sector, primarily due to its promising potential upside of nearly 99%. As a clinical-stage..

Arbutus Biopharma (ABUS) Stock Analysis: Exploring a 17.57% Potential Upside in Biotechnology

Arbutus Biopharma Corporation (NASDAQ: ABUS) stands as a compelling player in the biotechnology sector, particularly for those investors looking to delve into the dynamic world of..

iRadimed Corporation (IRMD) Stock Report: Exploring a 38% Upside Potential in the Healthcare Sector

Investors with an eye on the healthcare sector should pay close attention to iRadimed Corporation (NASDAQ: IRMD), a prominent player in the medical devices industry. Headquartered..

Claritev Corporation (CTEV) Stock Analysis: Healthcare Innovator with a 115% Upside Potential

Claritev Corporation (NASDAQ: CTEV), a key player in the healthcare sector, has caught the attention of investors, and for good reason. With a potential upside of..

Upstream Bio, Inc. (UPB) Stock Analysis: Exploring a 517% Potential Upside in the Biotech Arena

For investors with a keen eye on the biotechnology sector, Upstream Bio, Inc. (NASDAQ: UPB) presents a particularly intriguing opportunity. This clinical-stage biotech company, headquartered in..

Syndax Pharmaceuticals (SNDX) Stock Analysis: Unveiling a 106% Potential Upside in Biotech Innovation

Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX), a burgeoning player in the biotechnology sector, presents a compelling investment opportunity with a significant potential upside. With a market capitalization..

LifeMD, Inc. (LFMD) Stock Analysis: Exploring a 185% Upside with Strong Buy Ratings

LifeMD, Inc. (NASDAQ: LFMD), a key player in the burgeoning telehealth sector, stands out with its potential upside of 185.09%, driven by a strong consensus of..

Iovance Biotherapeutics, Inc. (IOVA) Stock Analysis: A Biotech Powerhouse with Promising Revenue Growth Amidst Volatile Market

Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a trailblazer in the biotechnology sector, is capturing investor attention with its innovative approach to treating solid tumor cancers. The company’s..

Arcus Biosciences, Inc. (RCUS) Stock Analysis: Eyeing a 58% Upside in a Challenging Biotech Landscape

Arcus Biosciences, Inc. (NASDAQ: RCUS), a clinical-stage biopharmaceutical company specializing in cancer therapies, is generating buzz among investors with its potential for significant upside. Despite operating..

Definitive Healthcare Corp. (DH) Stock Analysis: Can the 103% Upside Potential Attract Investors?

Definitive Healthcare Corp. (NASDAQ: DH), a key player in the health information services industry, offers a compelling narrative for investors navigating the healthcare sector. Founded in..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds